| The purpose of this article is to observe chiefly safety and efficacy of climateric syndrome treat with high potential therapies and hitting vital point.Suitable or eligible patients for selection.Seventy-six cases of climacteric syndrome was divided into treatment group(n=35) and control group (n=41) randomly. The former was treat with high potential therpies and hitting vital point,once a day .The later was treat with climacteric- syndrome- relievingtable.To be taken twice a day morning and night ,three tables each time.The changes of climacteric syndrome's 12 signs was observed before and after treatment in both groups: hot, sweaty, flush; Insomnia, memory loss; Fidgety irritable; Melancholy seem; Sexual difficulties; Joint muscle pain, twitch; Vertigo, tinnitus; Fatigue ; Headache, nausea; Skin feel abnormal; Urinary tract diseases; Palpitations, heartbeat. Three physiological indexes: luteinizing hormone (LH); Follicle-stimulating hormone (FSH); Estradiol (E2).Results: after 30 days of treatment, there is a obvious difference between the treatment group and controls. (p < 0.10), To treat menopausal symptoms, treatment group's method is better than control group's.(The response rate of treatment group'method is94.9% and the response rate of treatment control group'is 28.5%.) Conclusion: high potential therapies and hitting vital point has quite valid curative effects on climateric syndrome ,safety, and the patient had no pain, It has value of promotion. |